These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32950646)

  • 21. Milk thistle and the treatment of hepatitis.
    Giese LA
    Gastroenterol Nurs; 2001; 24(2):95-7. PubMed ID: 11847735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silybin and the liver: from basic research to clinical practice.
    Loguercio C; Festi D
    World J Gastroenterol; 2011 May; 17(18):2288-301. PubMed ID: 21633595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.
    Fallah M; Davoodvandi A; Nikmanzar S; Aghili S; Mirazimi SMA; Aschner M; Rashidian A; Hamblin MR; Chamanara M; Naghsh N; Mirzaei H
    Biomed Pharmacother; 2021 Oct; 142():112024. PubMed ID: 34399200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of UVA-induced damage to human keratinocytes by silymarin.
    Svobodová A; Zdarilová A; Malisková J; Mikulková H; Walterová D; Vostalová J
    J Dermatol Sci; 2007 Apr; 46(1):21-30. PubMed ID: 17289350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis.
    Li LH; Wu LJ; Tashiro SI; Onodera S; Uchiumi F; Ikejima T
    Int Immunopharmacol; 2006 Feb; 6(2):190-7. PubMed ID: 16399623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Silymarin on Diabetes Mellitus Complications: A Review.
    Stolf AM; Cardoso CC; Acco A
    Phytother Res; 2017 Mar; 31(3):366-374. PubMed ID: 28124457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silymarin: not just another antioxidant.
    Camini FC; Costa DC
    J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32134732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
    Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
    Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).
    Miranda SR; Lee JK; Brouwer KL; Wen Z; Smith PC; Hawke RL
    Drug Metab Dispos; 2008 Nov; 36(11):2219-26. PubMed ID: 18687803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silymarin and Its Role in Chronic Diseases.
    Neha ; Jaggi AS; Singh N
    Adv Exp Med Biol; 2016; 929():25-44. PubMed ID: 27771919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice.
    Guo Y; Wang S; Wang Y; Zhu T
    Pharm Biol; 2016 Dec; 54(12):2995-3000. PubMed ID: 27387273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Milk thistle in liver diseases: past, present, future.
    Abenavoli L; Capasso R; Milic N; Capasso F
    Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silychristin: Skeletal Alterations and Biological Activities.
    Biedermann D; Buchta M; Holečková V; Sedlák D; Valentová K; Cvačka J; Bednárová L; Křenková A; Kuzma M; Škuta C; Peikerová Ž; Bartůněk P; Křen V
    J Nat Prod; 2016 Dec; 79(12):3086-3092. PubMed ID: 28006905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro.
    Skottová N; Krecman V; Simánek V
    Phytother Res; 1999 Sep; 13(6):535-7. PubMed ID: 10479770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
    Mastron JK; Siveen KS; Sethi G; Bishayee A
    Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial organization of silybin biosynthesis in milk thistle [Silybum marianum (L.) Gaertn].
    Lv Y; Gao S; Xu S; Du G; Zhou J; Chen J
    Plant J; 2017 Dec; 92(6):995-1004. PubMed ID: 28990236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC; Girish C
    Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Milk Thistle (Silybum Marianum) as a Supportive Phytotherapeutic Agent in Oncology].
    Frassová Z; Rudá-Kučerová J
    Klin Onkol; 2017; 30(6):426-432. PubMed ID: 29271213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
    Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats.
    Cheng KC; Asakawa A; Li YX; Chung HH; Amitani H; Ueki T; Cheng JT; Inui A
    PLoS One; 2014; 9(1):e84550. PubMed ID: 24404172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.